French group's sales, listed on the CAC 40, are falling and its profit has been halved. Its turnover fell by almost 3% in 2023, to 6.5 billion euros, while its net profit was halved, to 308 million euros.
The generous reimbursements granted by the State to encourage players to carry out PCR tests no longer support the group's profitability. The war in Ukraine has, on the contrary, caused its costs to soar. Eurofins had anticipated these changes and lowered its forecasts during the summer, but its action nonetheless fell by 6.65% this Tuesday.